The global orthopaedic biomaterial market is majorly driven by the increasing older population leading to increase in the patient population, increasing surgeries, the various government supports, and growing awareness among young population towards health.

According to the United Nations, approximately over 962 million people were aged over 60 and above globally in 2017. The United Nations has also estimated that by 2050, the number of older population is likely to reach 425 million. This increasing aging population is likely to boost the growth of the global orthopaedic biomaterial market. Factors such as rigorous clinical and regulatory processes are likely to hamper the growth of the orthopaedic biomaterial market.

Global orthopaedic biomaterial market is expected to grow at a CAGR of 10.5% during the forecast period.